Global Human Injection Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 106

Published Date: 06 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

According to our (Global Info Research) latest study, the global Human Injection Flu Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Human Injection Flu Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Human Injection Flu Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Injection Flu Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Injection Flu Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris and AstraZeneca, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Human Injection Flu Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Market segment by Application
    6 Months to 3 Years
    > 3 Years

Major players covered
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    Jiangsu GDK
    KM Biologics

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Injection Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Injection Flu Vaccine, with price, sales, revenue and global market share of Human Injection Flu Vaccine from 2018 to 2023.
Chapter 3, the Human Injection Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Injection Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Injection Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Injection Flu Vaccine.
Chapter 14 and 15, to describe Human Injection Flu Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Human Injection Flu Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Trivalent Influenza Vaccine
        1.3.3 Quadrivalent Influenza Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 6 Months to 3 Years
        1.4.3 > 3 Years
    1.5 Global Human Injection Flu Vaccine Market Size & Forecast
        1.5.1 Global Human Injection Flu Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Human Injection Flu Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Human Injection Flu Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Human Injection Flu Vaccine Product and Services
        2.1.4 Sanofi Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Recent Developments/Updates
    2.2 CSL
        2.2.1 CSL Details
        2.2.2 CSL Major Business
        2.2.3 CSL Human Injection Flu Vaccine Product and Services
        2.2.4 CSL Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Human Injection Flu Vaccine Product and Services
        2.3.4 GSK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK Recent Developments/Updates
    2.4 Viatris
        2.4.1 Viatris Details
        2.4.2 Viatris Major Business
        2.4.3 Viatris Human Injection Flu Vaccine Product and Services
        2.4.4 Viatris Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Viatris Recent Developments/Updates
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Human Injection Flu Vaccine Product and Services
        2.5.4 AstraZeneca Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 AstraZeneca Recent Developments/Updates
    2.6 Hualan Bio
        2.6.1 Hualan Bio Details
        2.6.2 Hualan Bio Major Business
        2.6.3 Hualan Bio Human Injection Flu Vaccine Product and Services
        2.6.4 Hualan Bio Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Hualan Bio Recent Developments/Updates
    2.7 Changchun Institute of Biological
        2.7.1 Changchun Institute of Biological Details
        2.7.2 Changchun Institute of Biological Major Business
        2.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
        2.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Changchun Institute of Biological Recent Developments/Updates
    2.8 Sinovac
        2.8.1 Sinovac Details
        2.8.2 Sinovac Major Business
        2.8.3 Sinovac Human Injection Flu Vaccine Product and Services
        2.8.4 Sinovac Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sinovac Recent Developments/Updates
    2.9 Jiangsu GDK
        2.9.1 Jiangsu GDK Details
        2.9.2 Jiangsu GDK Major Business
        2.9.3 Jiangsu GDK Human Injection Flu Vaccine Product and Services
        2.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Jiangsu GDK Recent Developments/Updates
    2.10 KM Biologics
        2.10.1 KM Biologics Details
        2.10.2 KM Biologics Major Business
        2.10.3 KM Biologics Human Injection Flu Vaccine Product and Services
        2.10.4 KM Biologics Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Human Injection Flu Vaccine by Manufacturer
    3.1 Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Human Injection Flu Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Human Injection Flu Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Human Injection Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Human Injection Flu Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Human Injection Flu Vaccine Manufacturer Market Share in 2022
    3.5 Human Injection Flu Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Human Injection Flu Vaccine Market: Region Footprint
        3.5.2 Human Injection Flu Vaccine Market: Company Product Type Footprint
        3.5.3 Human Injection Flu Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Human Injection Flu Vaccine Market Size by Region
        4.1.1 Global Human Injection Flu Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Human Injection Flu Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Human Injection Flu Vaccine Average Price by Region (2018-2029)
    4.2 North America Human Injection Flu Vaccine Consumption Value (2018-2029)
    4.3 Europe Human Injection Flu Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Human Injection Flu Vaccine Consumption Value (2018-2029)
    4.5 South America Human Injection Flu Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Human Injection Flu Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Human Injection Flu Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Human Injection Flu Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Human Injection Flu Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Human Injection Flu Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Human Injection Flu Vaccine Market Size by Country
        7.3.1 North America Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Human Injection Flu Vaccine Market Size by Country
        8.3.1 Europe Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Human Injection Flu Vaccine Market Size by Region
        9.3.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Human Injection Flu Vaccine Market Size by Country
        10.3.1 South America Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Human Injection Flu Vaccine Market Size by Country
        11.3.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Human Injection Flu Vaccine Market Drivers
    12.2 Human Injection Flu Vaccine Market Restraints
    12.3 Human Injection Flu Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Human Injection Flu Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Human Injection Flu Vaccine
    13.3 Human Injection Flu Vaccine Production Process
    13.4 Human Injection Flu Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Human Injection Flu Vaccine Typical Distributors
    14.3 Human Injection Flu Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Human Injection Flu Vaccine Product and Services
    Table 6. Sanofi Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sanofi Recent Developments/Updates
    Table 8. CSL Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Major Business
    Table 10. CSL Human Injection Flu Vaccine Product and Services
    Table 11. CSL Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CSL Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Human Injection Flu Vaccine Product and Services
    Table 16. GSK Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. GSK Recent Developments/Updates
    Table 18. Viatris Basic Information, Manufacturing Base and Competitors
    Table 19. Viatris Major Business
    Table 20. Viatris Human Injection Flu Vaccine Product and Services
    Table 21. Viatris Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Viatris Recent Developments/Updates
    Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 24. AstraZeneca Major Business
    Table 25. AstraZeneca Human Injection Flu Vaccine Product and Services
    Table 26. AstraZeneca Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. AstraZeneca Recent Developments/Updates
    Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 29. Hualan Bio Major Business
    Table 30. Hualan Bio Human Injection Flu Vaccine Product and Services
    Table 31. Hualan Bio Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Hualan Bio Recent Developments/Updates
    Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 34. Changchun Institute of Biological Major Business
    Table 35. Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
    Table 36. Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Changchun Institute of Biological Recent Developments/Updates
    Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 39. Sinovac Major Business
    Table 40. Sinovac Human Injection Flu Vaccine Product and Services
    Table 41. Sinovac Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Sinovac Recent Developments/Updates
    Table 43. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 44. Jiangsu GDK Major Business
    Table 45. Jiangsu GDK Human Injection Flu Vaccine Product and Services
    Table 46. Jiangsu GDK Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Jiangsu GDK Recent Developments/Updates
    Table 48. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 49. KM Biologics Major Business
    Table 50. KM Biologics Human Injection Flu Vaccine Product and Services
    Table 51. KM Biologics Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. KM Biologics Recent Developments/Updates
    Table 53. Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2018-2023) & (Units)
    Table 54. Global Human Injection Flu Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 55. Global Human Injection Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 56. Market Position of Manufacturers in Human Injection Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 57. Head Office and Human Injection Flu Vaccine Production Site of Key Manufacturer
    Table 58. Human Injection Flu Vaccine Market: Company Product Type Footprint
    Table 59. Human Injection Flu Vaccine Market: Company Product Application Footprint
    Table 60. Human Injection Flu Vaccine New Market Entrants and Barriers to Market Entry
    Table 61. Human Injection Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
    Table 63. Global Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
    Table 64. Global Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 65. Global Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 66. Global Human Injection Flu Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 67. Global Human Injection Flu Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 68. Global Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
    Table 69. Global Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
    Table 70. Global Human Injection Flu Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Global Human Injection Flu Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Global Human Injection Flu Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 73. Global Human Injection Flu Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 74. Global Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
    Table 75. Global Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
    Table 76. Global Human Injection Flu Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. Global Human Injection Flu Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. Global Human Injection Flu Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 79. Global Human Injection Flu Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 80. North America Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
    Table 81. North America Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
    Table 82. North America Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
    Table 83. North America Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
    Table 84. North America Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
    Table 85. North America Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
    Table 86. North America Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. North America Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Europe Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
    Table 89. Europe Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
    Table 90. Europe Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
    Table 91. Europe Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
    Table 92. Europe Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
    Table 93. Europe Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
    Table 94. Europe Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
    Table 97. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
    Table 98. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
    Table 99. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
    Table 100. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
    Table 101. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
    Table 102. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 103. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 104. South America Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
    Table 105. South America Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
    Table 106. South America Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
    Table 107. South America Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
    Table 108. South America Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
    Table 109. South America Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
    Table 110. South America Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 111. South America Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
    Table 113. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
    Table 114. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
    Table 115. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
    Table 116. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
    Table 117. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
    Table 118. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 120. Human Injection Flu Vaccine Raw Material
    Table 121. Key Manufacturers of Human Injection Flu Vaccine Raw Materials
    Table 122. Human Injection Flu Vaccine Typical Distributors
    Table 123. Human Injection Flu Vaccine Typical Customers
List of Figures
    Figure 1. Human Injection Flu Vaccine Picture
    Figure 2. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Human Injection Flu Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Trivalent Influenza Vaccine Examples
    Figure 5. Quadrivalent Influenza Vaccine Examples
    Figure 6. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Human Injection Flu Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. 6 Months to 3 Years Examples
    Figure 9. > 3 Years Examples
    Figure 10. Global Human Injection Flu Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Human Injection Flu Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Human Injection Flu Vaccine Sales Quantity (2018-2029) & (Units)
    Figure 13. Global Human Injection Flu Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 14. Global Human Injection Flu Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Human Injection Flu Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Human Injection Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Human Injection Flu Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Human Injection Flu Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 29. Global Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Human Injection Flu Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Human Injection Flu Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 32. North America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Human Injection Flu Vaccine Market Drivers
    Figure 73. Human Injection Flu Vaccine Market Restraints
    Figure 74. Human Injection Flu Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2022
    Figure 77. Manufacturing Process Analysis of Human Injection Flu Vaccine
    Figure 78. Human Injection Flu Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Human Injection Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Global Human Injection Flu Vaccine Supply, Demand and Key Producers, 2023-2029

date 28 Jan 2023

date Pharma & Healthcare

The global Human Injection Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Human Injection Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Injection Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Injection Flu Vaccine market size was valued at USD 7856 million in 2023 and is forecast to a readjusted size of USD 11110 million by 2030 with a CAGR of 5.1% during review period.

Global Human Injection Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Global Human Injection Flu Vaccine Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Pharma & Healthcare

The global Human Injection Flu Vaccine market size is expected to reach $ 11110 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).

Product Tags

Human Injection Flu Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>